Seqcoast Genomics, LLC
Portsmouth, NH Part of Oakhurst Biosciences, Inc.
- UEI
- P7FFRKSCXMD5
- CAGE
- 9ZCR8
- Primary NAICS
- 541380 Testing Laboratories and Services
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
Portsmouth, NH
EWHPEFFN2M17
-
Parent
Portsmouth, NH
EWHPEFFN2M17
- SAM.gov registration date
- Physical address
- 25 New Hampshire Ave #205, Portsmouth, NH 03801, USA
- Website
- seqcoast.com
- Founded
- 2022
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $42,801 |
| FY2025 | $33,848 |
| FY2024 | $11,190 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $42,801 |
Contract awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Cosmosid, Inc. | Rockville, MD | 541690 Other Scientific and Technical Consulting Services |
| Genohub, Inc. | Austin, TX | 541990 All Other Professional, Scientific, and Technical Services |
| Floragenex, Inc. | Beaverton, OR | 541990 All Other Professional, Scientific, and Technical Services |
| Seqcenter LLC | Pittsburgh, PA | 541380 Testing Laboratories and Services |
| Creative Biomart | Shirley, NY | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Seqcoast Genomics, LLC, a Portsmouth, New Hampshire-based genomic sequencing services provider, operates as a wholly owned subsidiary of Oakhurst Biosciences, Inc., delivering DNA extraction, metagenomic sequencing, and multi-omics analytical services to federal research agencies exclusively as a prime contractor. The company competes full-and-open without set-aside designations on most awards, though it has received two Total Small Business set-aside purchase orders from USDA Agricultural Research Service.
Seqcoast's capability portfolio centers on Illumina-based next-generation sequencing, DNA metagenomic analysis, and multi-omics characterization (metabolomics, proteomics, transcriptomics, genomics) of environmental, microbial, and plant samples. Representative work includes a $21,400 purchase order from the National Human Genome Research Institute (September 2026) for DNA extraction and Illumina sequencing supporting Julie Segre's laboratory studies of the human skin microbiome; a $14,974 order from USDA Agricultural Research Service Northeast Area (October 2025) for DNA metagenomic sequencing of 192 pig fecal and digesta samples using Illumina Flex technology; and an $11,190 Total Small Business purchase order from USDA ARS (September 2024) for non-human whole genome sequencing of 175 bacterial genome samples. In September 2025, Seqcoast won a $500,000 multiple-award Blanket Purchase Agreement with the U.S. Army Corps of Engineers Engineer Research and Development Center for multi-omics characterization of cold regions samples, with place of performance in Hanover, New Hampshire and completion by September 2030.
Customer concentration is dispersed across three agencies. The Department of the Army Corps of Engineers ERDC dominates potential-value ranking with the single $500,000 BPA (85% of combined potential value), while USDA Agricultural Research Service Northeast Area places three orders totaling $45,000 (8% of combined potential value), and the National Institutes of Health National Human Genome Research Institute holds two awards totaling $43,000 (7% of combined potential value). Activity has grown modestly—one award in 2024, three in 2025, two in 2026—but remains low-volume; two awards with a combined potential value of $43,000 reach ultimate completion within the next twenty-four months and face recompete exposure. Six of six awards are prime positions; Seqcoast carries no subcontract footprint in the source data. Obligated dollars total $88,000 against combined potential value of $588,000 (15% invoiced), indicating early program execution across recent awards.
Quick answers
Is Seqcoast Genomics, LLC registered in SAM.gov?
Yes. Seqcoast Genomics, LLC's SAM.gov registration is active through December 13, 2026.
How much has Seqcoast Genomics, LLC received in federal contracts?
Federal contracts obligated $33,848 to Seqcoast Genomics, LLC in fiscal year 2025 and $87,839 in fiscal years 2023 through 2027.
How does Seqcoast Genomics, LLC rank among federal contractors?
Seqcoast Genomics, LLC ranked #32 in PSC AA in FY2025.
What is Seqcoast Genomics, LLC's most recent federal award?
Seqcoast Genomics, LLC's most recent federal contract award is Nhgri (75N98026P01384), from Office of Logisitics and Acquisition Operations (NIH), on September 3, 2026.
On GovTribe
See Seqcoast Genomics, LLC's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors